Sponsor

Praxis Precision Medicines Inc.

United States 99 High Street Floor 30th, 02110-2345, United States

About the sponsor

Clinical research focuses on adult epilepsy, including focal epilepsy and primary generalized tonic-clonic seizures, with attention to seizure control and treatment response in people using background anti-seizure medications.

Focal onset seizures
Primary generalized tonic-clonic seizures
Seizure frequency

The sponsor also studies photoparoxysmal electroencephalogram response in epilepsy, reflecting interest in seizure-related neurophysiological markers.

About Specializations

Praxis Precision Medicines Inc. runs clinical trials in conditions such as Partial seizures, Generalised tonic-clonic seizure, Epileptic encephalopathy, Epilepsy, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Quick filters

7 clinical trials

Generalised tonic-clonic seizure+1

Recruiting

InvestigationalNo placebo

Study of PRAX-628 to evaluate safety and effectiveness in adults with epilepsy who have focal seizures or generalized tonic-clonic seizures

InvestigationalNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Prax-628
Sponsor:Praxis Precision Medicines Inc.

Contact Research Centre

Epileptic encephalopathy

Recruiting

InvestigationalNo placebo

Study of Elsunersen in Children with SCN2A Developmental and Epileptic Encephalopathy to Reduce Seizures

InvestigationalNo placebo

Germany

Participants:0–17 years · 18–64 years
Substances:5'-MOEMC-(SP)-MOEMC-(P)-MOEA-(P)-MOEMC-(P)-MOEG-(P)-MOEA-(P)-DMC-(SP)-DA-(SP)-DT-(SP)-DA-(SP)-DT-(SP)-DT-(SP)-DT-(SP)-DT-(SP)-DT-(SP)-DMC-(SP)-MOET-(P)-MOEA-(SP)-MOEMC-(SP)-MOEA 3'
Sponsor:Praxis Precision Medicines Inc.